The LILRB4 gene helps certain white blood cells put the brakes on immune activity, which keeps inflammation and tissue damage more controlled. If it does not work as expected, immune signaling may become less balanced. In medicine, this gene is important because some leukemia cells, especially in acute myeloid leukemia, can use LILRB4 to avoid immune attack, so it has become a focus of research and new treatments.
What is a gene?
Genes are sections of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the information needed to produce proteins, the working parts of cells. Others mainly help determine when certain processes take place, where they occur, and how strongly they run. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. To explore this subject in greater depth, you can find more in the LearnHub.
Overview
LILRB4Gene function
What if the gene works
The LILRB4 gene helps certain white blood cells calm immune activity. This supports a more controlled response and can limit unnecessary inflammation.
Risk
What if the gene does not work
If the LILRB4 gene works less well, certain white blood cells may receive weaker “slow down” signals and become less controlled. Milder variants may have little effect, while more severe variants can more clearly disrupt immune cell communication.
Treatment
What does that mean for your treatment
At present, no treatment or management approach tied to the LILRB4 gene is established for people with a pathogenic or loss-of-function variant. The LILRB4 gene is being studied as a drug target and biomarker, especially in some myeloid leukemias, but this has not yet led to routine variant guided treatment choices.
Gene function
What if the gene works
Some white blood cells need built in brakes as well as alarms. In immune cells such as monocytes and dendritic cells, the LILRB4 gene helps keep responses measured and coordinated. Understanding the LILRB4 gene's function helps explain how the body balances protection against germs with tolerance toward normal tissues.
In monocytes and dendritic cells, the LILRB4 gene makes a surface receptor that sends calming signals. This helps these cells avoid reacting too strongly when they meet routine immune triggers.
Its receptor acts like a brake on inflammation related signals inside the cell. This supports a more controlled immune response and helps limit unnecessary tissue irritation.
Activity from the LILRB4 gene helps certain immune cells stay more tolerant when they interact with T cells. This supports recognition of normal body tissues as part of the self.
The LILRB4 receptor helps myeloid cells adjust how strongly they activate nearby immune cells. This fine tunes immune communication during everyday immune surveillance.
What is a variant?
A genetic variant refers to a slight difference in the DNA sequence of a gene. Variants like these are common and form part of normal human diversity, including variation in appearance, metabolism, and the body’s response to environmental influences. Many do not lead to any noticeable effect and simply reflect naturally occurring genetic variation. Sometimes, though, a variant can affect how a gene functions more substantially and may play a role in, or cause, a genetic condition.
Genetic variants
What if the gene does not work
Variants in the LILRB4 gene can change the receptor’s shape, stability, or placement on the cell surface, which may weaken ligand binding and signaling. This is how LILRB4 gene variants affect protein function: milder changes may lower folding or expression, while more severe variants can truncate the protein or keep it from reaching the cell surface. Stronger loss of function variants can markedly reduce receptor interactions and signaling.
How variants are linked to conditions
The LILRB4 gene does not yet have a broadly confirmed link to a specific inherited health condition, although research on LILRB4 gene variants and health conditions is still developing. If you have a reported variant in the LILRB4 gene, your doctor or genetic counselor can explain what that result may mean in the context of your own health and family history.
A variant is not necessarily a diagnosis
Gene variants are a normal feature of human biology and are common across the general population. Most variants do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are involved. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the LILRB4 gene. If you have concerns about your personal or family risk, a doctor or genetic counselor can help put genetic results in context.
Inheritance of LILRB4 variants
For people trying to understand how LILRB4 gene variants are inherited, there is not yet a broadly confirmed inheritance pattern tied to a specific LILRB4-related condition. As research develops, this picture may become clearer. The LILRB4 gene is located on chromosome 19, which is an autosome, so each person inherits one copy from each parent. This means any inherited LILRB4 variant would generally be passed through the usual patterns seen for genes on the numbered chromosomes.
What does my LILRB4 result mean for my family?
There is not yet a broadly confirmed inherited pattern linking the LILRB4 gene to a specific, well-recognized genetic condition in families. If you have a LILRB4 result and want to understand what it could mean for relatives, a doctor or genetic counselor can help explain it in the context of your exact finding and family history.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the LILRB4 gene, a lab can analyze DNA from a blood or saliva sample. This testing for LILRB4 variants reads the gene's code and compares it with the usual sequence to identify changes. Results may show a known variant, no relevant variant, or a change that is not yet fully understood.
When should I consider getting a genetic test?
There is not yet a broadly established, LILRB4-specific reason for genetic testing in routine care. Decisions about testing are best made with a doctor or genetic counselor, based on your health history, family history, and the reason testing is being considered.
A genetic result is only one part of your health story
A genetic result can be informative, but what it can tell you varies with the condition and the specific type of variant involved. How the body works over time is also shaped by many factors, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best considered together with other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. A treatment that works well for one person may work less well for another, or may cause more side effects, because the body can absorb, process, and respond to drugs in different ways. These inherited differences are common and can influence how strongly a medicine works or how sensitive someone is to it.
What is Pharmacogenetics?
Pharmacogenetics examines how inherited genetic differences affect the way people respond to medications. It studies links between genes and drugs to better understand why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body handles it. This information can support more informed, individualized treatment decisions. More on this topic is available in the LearnHub.
Drugs influenced by the LILRB4 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication response, so general questions about medicines, side effects, or treatment changes are best discussed with your doctor.
History
LILRB4 entered the scientific literature in the late 1990s, when researchers were mapping a group of closely related immune receptor genes on chromosome 19. It was first described under names such as ILT3 and CD85k before the current name, the LILRB4 gene, became standard. Initially understood only through visible traits, later recognized as tied to a specific gene, its naming reflected a broader effort to organize this newly identified receptor family. From these first observations, research expanded steadily. As classification systems improved, scientists placed the LILRB4 gene within the leukocyte immunoglobulin-like receptor family, which helped unify earlier reports under one framework. This early naming and reclassification history shaped how the gene is studied today in immunology and blood cancer research.